Brief: Venus Remedies Says Consolidates In ASEAN, Gets Marketing Approval For Six Chemotherapy Drugs From Philippines
16/10/2023 05:06
Oct 16 (Reuters) - Venus Remedies Ltd VENR.NS :
* VENUS REMEDIES CONSOLIDATES IN ASEAN, GETS MARKETING
APPROVAL
FOR SIX CHEMOTHERAPY DRUGS FROM PHILIPPINES
* VENUS REMEDIES' ONCOLOGY WING HAS ALSO SECURED MARKETING
AUTHORISATION FROM MYANMAR FOR ANOTHER CHEMOTHERAPY DRUG
Source text for Eikon: ID:nBSE20P725
Further company coverage: VENR.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Venus Remedies
See all newsBrief: Venus Remedies Sept-Quarter Consol Net Profit 256.5 Million Rupees
Brief: Venus Remedies Secured Five Marketing Authorisations Across Kazakhstan, Peru, Kuwait And Argentina
India's Venus Remedies rises after quarterly profit more than doubles
Brief: Venus Remedies June-Quarter Consol Net Profit 229.7 Million Rupees
India raises price cap on cancer drugs to tackle shortage